1-1 of 1
Irene Fuss
Close
Sort by
Journal Articles

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma

Clinical Trials & Observations
Peter Borchmann, Roland Schnell, Irene Fuss, Oliver Manzke, Thomas Davis, Lionel D. Lewis, Detlev Behnke, Claudia Wickenhauser, Petra Schiller, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2002) 100 (9): 3101–3107.
https://doi.org/10.1182/blood-2001-12-0295
Published: 2002